Literature DB >> 16014353

Insulin sensitivity by oral glucose minimal models: validation against clamp.

Chiara Dalla Man1, Kevin E Yarasheski, Andrea Caumo, Heather Robertson, Gianna Toffolo, Kenneth S Polonsky, Claudio Cobelli.   

Abstract

Measuring insulin sensitivity in the presence of physiological changes in glucose and insulin concentrations, e.g., during a meal or OGTT, is important to better understand insulin resistance in a variety of metabolic conditions. Recently, two oral minimal models have been proposed to measure overall insulin sensitivity (S(I)) and its selective effect on glucose disposal (S(I)*) from oral tests. S(I) and S(I)* have been successfully validated against multiple tracer meal estimates, but validation against euglycemic hyperinsulinemic clamp estimates is lacking. Here, we do so in 21 subjects who underwent both a multiple-tracer OGTT and a labeled euglycemic hyperinsulinemic clamp. Correlation between minimal-model S(I), S(I) and corresponding clamp estimates S(I)(*clamp), S(I)(*clamp) was satisfactory, respectively r = 0.81, P < 0.001, and r = 0.71, P < 0.001. S(I) was significantly lower than S(I)(clamp) (8.08 +/- 0.89 vs. 13.66 +/- 1.69 10(-4) dl.kg(-1).min(-1) per microU/ml, P = 0.0002), whereas S(I) and S(I)(*clamp) were very similar (8.17 +/- 1.59 vs. 8.84 +/- 1.39 10(-4) dl.kg(-1).min(-1) per microU/ml, P = 0.52). These results add credibility to the oral minimal-model method as a simple and reliable physiological tool to estimate S(I) and S(I)*, also in large-scale clinical trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014353     DOI: 10.1152/ajpendo.00076.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  46 in total

1.  A simple robust method for estimating the glucose rate of appearance from mixed meals.

Authors:  Pau Herrero; Jorge Bondia; Cesar C Palerm; Josep Vehí; Pantelis Georgiou; Nick Oliver; Christofer Toumazou
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  A composite model of glucagon-glucose dynamics for in silico testing of bihormonal glucose controllers.

Authors:  Pau Herrero; Pantelis Georgiou; Nick Oliver; Monika Reddy; Desmond Johnston; Christofer Toumazou
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

3.  Advances in stable isotope tracer methodology part 1: hepatic metabolism via isotopomer analysis and postprandial lipolysis modeling.

Authors:  Cecilia Diniz Behn; Eunsook S Jin; Kate Bubar; Craig Malloy; Elizabeth J Parks; Melanie Cree-Green
Journal:  J Investig Med       Date:  2019-09-24       Impact factor: 2.895

4.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

5.  Weight loss therapy improves pancreatic endocrine function in obese older adults.

Authors:  Dennis T Villareal; Marian R Banks; Bruce W Patterson; Kenneth S Polonsky; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

6.  A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects.

Authors:  O Vahidi; K E Kwok; R B Gopaluni; F K Knop
Journal:  Med Biol Eng Comput       Date:  2015-10-22       Impact factor: 2.602

7.  Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements.

Authors:  Gregory C Henderson; Ketan Dhatariya; G Charles Ford; Katherine A Klaus; Rita Basu; Robert A Rizza; Michael D Jensen; Sundeep Khosla; Peter O'Brien; K Sreekumaran Nair
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

8.  Use of a simple liquid meal test to evaluate insulin sensitivity and beta-cell function in children.

Authors:  P C Chandler-Laney; P B Higgins; W Granger; J Alvarez; K Casazza; J R Fernandez; C Dalla Man; C Cobelli; B A Gower
Journal:  Pediatr Obes       Date:  2013-02-28       Impact factor: 4.000

9.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

10.  TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

Authors:  Dennis T Villareal; Heather Robertson; Graeme I Bell; Bruce W Patterson; Hung Tran; Burton Wice; Kenneth S Polonsky
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.